Impact of different methods for describing the extent of prior antibiotic exposure on the association between antibiotic use and antibiotic-resistant infection

Infection Control and Hospital Epidemiology

Volumn 28, Issue 6, 2007, Pages 647-654

  Hyle, Emily P ^a   Bilker, Warren B ^a   Gasink, Leanne B ^a   Lautenbach, Ebbing ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CEPHALOSPORIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; METRONIDAZOLE; PENICILLIN G; QUINOLONE DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATION; COMORBIDITY; DRUG EXPOSURE; DRUG USE; ESCHERICHIA COLI; HOSPITALIZATION; HUMAN; INFECTION RISK; KLEBSIELLA; RISK FACTOR; SYSTEMATIC REVIEW;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; KLEBSIELLA; KLEBSIELLA INFECTIONS; MULTIVARIATE ANALYSIS; RESEARCH DESIGN; RISK FACTORS;

EID: 34250766575     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/516798     Document Type: Article

References (37)

1. Smolinski M, Hamburg M, Lederberg J. Microbial Threats to Health: Emergence, Detection, and Response. Washington, DC: Institute of Medicine; 2003:32.
2. Livermore D. Can better prescribing turn the tide of resistance? Nat Rev Microbiol 2004; 2:73-78.
3. Harbarth S, Samore M. Antimicrobial resistance determinants and future control. Emerg Infect Dis 2005; 11:794-801.
4. Patterson J. Antibiotic utilization: is there an effect on antimicrobial resistance? Chest 2001; 119:426S-430S.
5. Safdar N, Maki D. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002; 136:834-844.
6. Bradford P. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14:933-951.
7. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001; 32:1162-1171.
8. Sun GW, Shook TL, Kay GL. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol 1996; 49:907-916.
9. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989; 129:125-137.
10. Dromigny J, Nabeth P, Juergens-Behr A, Perrier-Gros-Claude JD. Risk factors for antibiotic-resistant Escherichia coli isolated from community-acquired urinary tract infections in Dakar, Senegal. J Antimicrob Chemother 2005; 56:236-239.
11. Mendelson G, Hait V, Ben-Israel J, Gronich D, Granot E, Raz R. Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur J Clin Microbiol Infect Dis 2005; 24:17-22.
12. Qavi A, Segal-Maurer A, Mariano N, et al. Increased mortality associated with a clonal outbreak of ceftazidime-resistant Klebsiella pneumoniae: a case-control study. Infect Control Hosp Epidemiol 2005; 26:63-68.
13. Kang CI, Kim SH, Kim DM, et al. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2004; 25:860-867.
14. Kang CI, Kim SH, Park WB, et al. Clinical outcome of bacteremic spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase- producing Escherichia coli and Klebsiella pneumoniae. Korean J Intern Med 2004; 19:160-164.
15. Lee SO, Lee ES, Park SY, Kim SY, Seo YH, Cho YK. Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2004; 25:832-837.
16. Panhotra B, Saxena A, Al-Ghamdi A. Extended-spectrum β-lactamase- producing Klebsiella pneumoniae hospital acquired bacteremia: risk factors and clinical outcome. Saudi Med J 2004; 25:1871-1876.
17. Paterson DL, Ko WC, Von Gottberg A, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med 2004; 140:26-32.
18. Rodriguez-Bano J, Navarro MD, Romero L, et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004; 42:1089-1094.
19. Yan JJ, Ko WC, Wu JJ, Tsai SH, Chuang CL. Epidemiological investigation of bloodstream infections of extended-spectrum cephalosporin-resistant Escherichia coli in a Taiwanese teaching hospital. J Clin Microbiol 2004; 42:3329-3332.
20. Lin M, Huang M, Lai S. Risk factors in the acquisition of extended-spectrum β-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan. J Hosp Infect 2003; 53:39-45.
21. Du B, Long Y, Lin H, et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med 2002; 28:1718-1723.
22. Ho PL, Chan WM, Tsang KW, Wong SS, Young K. Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes. Scand J Infect Dis 2002; 34:567-573.
23. Kim B, Woo JH, Kim MN, et al. Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia. J Hosp Infect 2002; 52:99-106.
24. Pena C, Pujol M, Ardanuy C, et al. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum β-lactamase. J Hosp Infect 2001; 47:53-59.
25. Wiener J, Quinn J, Bradford P. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281:517-523.
26. Schiappa DA, Hayden MK, Matushek MG, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 1996; 174:529-536.
27. DeChamps C, Rouby D, Guelon D, et al. A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamase. J Hosp Infect 1991; 18:5-13.
28. Bisson G, Fishman NO, Patel JB, Edelstein PH, Lautenbach E. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. Infect Control Hosp Epidemiol 2002; 23:254-260.
29. Pena C, Ardanuy C, Ricart A, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1998; 42:53-58.
30. Piroth L, Aube H, Doise JM, Vincent-Martin M. Spread of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: are β-lactamase inhibitors of therapeutic value? Clin Infect Dis 1998; 27:76-80.
31. Pena C, Pujol M, Ricart A, et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended-spectrum β-lactamase in the intensive care unit. J Hosp Infect 1997; 35:9-16.
32. Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 2004; 23:163-167.
33. Lucet J, Chevret S, Deere D, et al. Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 1996; 22:430-436.
34. Harris AD, Karchmer TB, Carmeli Y, Samore MH. Methodological principles of case-control studies that analyzed risk factors for antibiotic-resistance: a systematic review. Clin Infect Dis 2001; 32:1055-1061.
35. D'Agata EM, Cataldo MA, Cauda R, Tacconelli E. The importance of addressing multidrug resistance and not assuming single-drug resistance in case-control studies. Infect Control Hosp Epidemiol 2006; 27:670-674.
36. Royston P, Altman D, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 2006; 25:127-141.
37. Dunbar L, Wunderink LG, Habib MP, et al. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis 2003; 37:752-760.